Filing Details
- Accession Number:
- 0001140361-11-056992
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-12-12 14:42:18
- Reporting Period:
- 2011-12-08
- Filing Date:
- 2011-12-12
- Accepted Time:
- 2011-12-12 14:42:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1375247 | Obagi Medical Products Inc. | OMPI | Pharmaceutical Preparations (2834) | 954658730 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1382901 | S. David Goldstein | C/O Obagi Medical Products, Inc. 3760 Kilroy Airport Way, Suite 500 Long Beach CA 90806 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-12-08 | 1,000 | $9.84 | 21,500 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-12-09 | 21,500 | $9.75 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2011-12-09 | 33,334 | $5.86 | 33,334 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-12-09 | 33,334 | $9.75 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2011-12-09 | 33,334 | $0.00 | 33,334 | $5.86 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 16,666 | 2019-03-03 | No | 4 | M | Direct |
Footnotes
- Such transaction was executed in multiple trades at prices ranging from $9.80 to $9.86. The price reported reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares and prices at which the trades were effected.
- Fully vested and immediately exercisable.
Billionaire Hedge Funds
